Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Debjeet Sur

53 indexed publications match this author name.

ORCID: 0000-0001-5525-5156
OpenAlex: https://openalex.org/A5064096149

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 32 Clinical Trial 25 Safety 24 Review Article 19 Anxiety 17 Treatment-Resistant Depression 15 Mechanism of Action 14 Receptor Pharmacology 12 Brain Imaging 11 Addiction 11 Aging 10 Adverse Events 10

Journals

ClinicalTrials.gov 7 Psychiatry research 3 Biological Psychiatry 3 Psychedelic medicine (New Rochelle, N.Y.) 2 PsyArXiv 2 Scientific reports 2 Journal of psychopharmacology (Oxford, England) 2 International Journal of Surgery Global Health 2

Publication history

Psychedelics align brain activity with context.Nature · 2026-08-19 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-07-31 Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition - Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)Zenodo (CERN European Organization for Nuclear Research) · 2026-07-14 Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?EcoEvoRxiv · 2026-07-01 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine & Surgery · 2026-07-01 Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01 The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSDClinicalTrials.gov · 2026-05-26 Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)ClinicalTrials.gov · 2026-05-14 Psychedelics, Eleusis, and the Invention of Religious Experience.Psychedelic medicine (New Rochelle, N.Y.) · 2026-03-01 India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.Indian journal of psychological medicine · 2026-02-05 Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.Annals of medicine and surgery (2012) · 2026-01-01 Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20 Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.Journal of eating disorders · 2025-07-24 Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Psychiatry research · 2025-07-01 The pharmacological treatment of anxiety in people with eating disorders: A systematic review.Pharmacological research · 2025-06-01 187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09 186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09 323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-09 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28 Psychedelics are Bringing a new wind to the PharmacopoeiaNeuroscience and Neurological Surgery · 2025-02-27 Novel treatments for anorexia nervosa: Insights from neuroplasticity research.European eating disorders review: the journal of the Eating Disorders Association · 2024-11-01 A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)ClinicalTrials.gov · 2024-08-15 Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer PatientsJournal of Natural Remedies · 2024-07-31 Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First RespondersClinicalTrials.gov · 2024-06-24 Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Journal of affective disorders · 2024-06-15 Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.Scientific reports · 2024-04-17 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08 Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for PsychiatristsCurrent Psychiatry Research and Reviews · 2024-01-21 Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Psychiatry research · 2023-11-01 An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05 Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-02 Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military VeteransClinicalTrials.gov · 2023-05-25 Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.Neurosurgery · 2023-04-01 The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01 Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.Frontiers in psychiatry · 2023-01-01 The psychedelic renaissance: can psilocybin possibly combat depression?International Journal of Surgery Global Health · 2022-11-01 The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01 Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybinSURG Journal · 2022-06-01 Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01 Blinding and expectancy confounds in psychedelic randomized controlled trials.Expert review of clinical pharmacology · 2021-09-01 Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08 The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01 4 Psychedelics: therapeutic mechanismsJournal of Neurology Neurosurgery & Psychiatry · 2020-07-20 DARK Classics in Chemical Neuroscience: Ibogaine.ACS chemical neuroscience · 2018-10-17 Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Scientific reports · 2017-04-19 Return of the psychedelics: Psilocybin for treatment resistant depression.Asian journal of psychiatry · 2016-12-01 Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18 PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSISJournal of Neurology Neurosurgery & Psychiatry · 2013-08-06

Author directory